AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

ResMed Inc. (RMD)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

230.19

-2.79 (-1.20%)

At close: Feb 18, 2025, 3:59 PM

230.58

0.17%

After-hours: Feb 18, 2025, 07:00 PM EST

undefined% (undefined)

Bid	226
Market Cap	33.81B
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	8.48
PE Ratio (ttm)	27.15
Forward PE	n/a
Analyst	Hold

Ask	234.94
Volume	666,615
Avg. Volume (20D)	857,123
Open	231.10
Previous Close	232.98
Day's Range	228.87 - 232.96
52-Week Range	170.56 - 263.05
Beta	undefined

About RMD

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use i...

[Show more]

Industry Medical - Instruments & Supplies

Sector Healthcare

IPO Date Jun 2, 1995

Employees 9,980

Stock Exchange NYSE

Ticker Symbol RMD

Website https://www.resmed.com

Full Company Profile

Analyst Forecast

According to 12 analyst ratings, the average rating for RMD stock is "Hold." The 12-month stock price forecast is $260, which is an increase of 12.95% from the latest price.

Buy 41.67%

Hold 50.00%

Sell 8.33%

Stock Forecasts

Next Earnings Release

ResMed Inc. is scheduled to release its earnings on Apr 24, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

2 weeks ago

-8.33%

ResMed shares are trading lower. The company repor... Unlock content with Pro Subscription

1 month ago

-2.57%

ResMed shares are trading lower after rival Eli Lilly received approval for Zepbound as an obstructive sleep apnea treatment for obese adults.

News

4 days ago · zacks.com

Here's Why ResMed (RMD) Could be Great Choice for a Bottom Fisher

ResMed (RMD) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Str...

1 week ago · zacks.com

Why ResMed (RMD) is a Top Growth Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

1 week ago · seekingalpha.com

Revisiting ResMed In 2025: Strong Q2 Financial Results And The Growing Demand For Sleep Apnea Solutions

ResMed reported $1.28 billion in revenue and $2.43 EPS, driven by strong demand for AirSense 11 and effective cost management. Rising awareness of sleep apnea, aided by wearable devices like Apple Wat...

2 weeks ago · zacks.com

Trump Tariffs Threaten MedTech: 3 Stocks to Mitigate Risks

Three companies that are better positioned to withstand Trump's tariff challenges are ResMed, Hims & Hers Health and Medtronic.

2 weeks ago · zacks.com

Is ResMed (RMD) a Solid Growth Stock? 3 Reasons to Think "Yes"

ResMed (RMD) possesses solid growth attributes, which could help it handily outperform the market.

2 weeks ago · benzinga.com

Stock Of The Day: Trading The Range In ResMed

ResMed Inc. RMD shares are consolidating on Monday. This follows Friday's decline of more than 8%.

2 weeks ago · zacks.com

Here's Why ResMed (RMD) is a Strong Momentum Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

2 weeks ago · zacks.com

ResMed Inc. (RMD) Hits Fresh High: Is There Still Room to Run?

ResMed (RMD) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

2 weeks ago · seekingalpha.com

ResMed Inc. (RMD) Q2 2025 Earnings Call Transcript

ResMed Inc. (NYSE:RMD ) Q2 2025 Earnings Conference Call January 30, 2025 4:30 PM ET Company Participants Mike Ott - Senior Manager, IR Michael Farrell - Chairman and Chief Executive Officer Brett San...

2 weeks ago · fool.com

ResMed: Digital Health Drives Q2 Growth

ResMed (RMD 1.89%), a leader in sleep apnea and respiratory care solutions, reported strong fiscal 2025 second-quarter earnings on Thursday, Jan. 30. The medical device company outperformed analyst co...

Load More News